“Early detection can reduce lung cancer death rates by 20% — that’s significant,” Dr. Gorbatov says. “In some cases when we ...

Russia has reportedly developed a vaccine against cancer that it will launch early next year. The jab, which will be free of cost, will treat patients instead of preventing the disease in the general ...

Lung cancer screening with low-dose CT can detect extensive coronary artery calcium, an independent predictor of all-cause ...

The American Lung Association said lung cancer is the leading cause of cancer deaths in the Sunshine State as well as the United States. And that the rate of early diagnosis in Florida is far too low ...

AstraZeneca's Imfinzi gains FDA Priority Review for bladder cancer. Key trial data shows improved survival and progression ...

Precision medicine is an innovative approach that tailors treatment to the unique genetic and molecular characteristics of a ...

The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), as a single agent, for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has ...

More and more countries are legalising voluntary assisted dying. But who is accessing it? The results of a recent ...

According to the 2022 Singapore Cancer Registry, lung cancer has one of ... “I understand that when patients are first diagnosed, it feels like a death sentence. But it’s not.” ...

Lung cancer screening with low-dose chest computed tomography (CT) may detect more than just lung cancer. As new research in ...

ACTUALLY, SCREENING IS COMING FOR PATIENTS WHO DON’T HAVE ANY SYMPTOMS AT ALL. OKAY, IT’S BETTER TO HAVE BECAUSE LUNG CANCER, BY THE TIME YOU HAVE SYMPTOMS, IT’S A LOT OF TIMES IT’S TOO ...

AstraZeneca’s IMFINZI ® (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following ...